Vicore Pharma AB Alternatives & Competitors
12 companies similar to Vicore Pharma AB
Companies similar to Vicore Pharma AB
Kither Biotech
Improving treatment for patients suffering from incurable respiratory diseases
Turin, Italy
AnnJi Pharmaceutical Co., Ltd.
Taiwan's Leading New Drug Developer In Dermatology & Neurology
Taiwan
Avalyn Pharma
Revolutionizing respiratory care with every breath
Boston, United States
Syntara
Syntara (ASX:SNT) is an ASX-listed clinical stage drug developer for diseases linked to fi...
Australia
Track all Vicore Pharma AB competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Pliant Therapeutics
We are transforming the lives of patients by developing best-in-class treatments for fibro...
South San Francisco, Unit...
Santhera Pharmaceuticals
We are dedicated to developing medicines to meet the needs of patients living with rare di...
Pratteln, Switzerland
Savara Inc.
Savara is a clinical stage biopharmaceutical company focused on rare respiratory diseases....
United States
Ascelia Pharma AB
Ascelia Pharma is an oncology-dedicated orphan drug company listed on Nasdaq Stockholm und...
Malmo, Sweden
CHORD Therapeutics
Chord Therapeutics is dedicated to bringing new treatments to patients affected by orphan...
Geneva, Switzerland
Emmaus Life Sciences, Inc
Improving the lives of people with rare disease.
Torrance, United States
Chance Pharmaceuticals 畅溪制药
A clinical-stage biotech company focusing on discovering, developing and commercializing i...
China
F2G
The rare fungal disease company
Manchester, United Kingdo...
About Vicore Pharma AB
Vicore Pharma AB is a Swedish biopharmaceutical company founded in 2009 that focuses on developing drugs with disease-modifying potential for respiratory diseases. It is currently advancing Buloxibutid (C21), the first-in-class orally available small molecule angiotensin II type 2 receptor agonist, through phase 2a dev...
Pharmaceutical Company, Clinical-stage, Respiratory Diseases, Idiopathic Pulmonary Fibrosis, ATRAG, Phase 2a Development, Digital Therapeutic, Breakthrough Device Designation, Drug Development, Orphan Drug Designation, Rare Diseases, Nasdaq Stockholm, Astra Zeneca, Bioventurehub, Innovative Medicines
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Vicore Pharma AB and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Vicore Pharma AB on 11 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
